Inhibition of PLK4 by centrinone dephosphorylates and translocates TFEB and TFE3 to the nucleus and supports cancer proliferation in the absence of centrosome, implying there are impediments to adopting centrosome depletion alone as a treatment strategy. Here, PLK4 is linked to cancer.